tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Cassorla, 42 are a BUY (77.78%), 12 are a HOLD (22.22%).
Analyst Jason Cassorla, currently employed at CITI, carries an average stock price target met ratio of 46.43% that have a potential upside of 28.3% achieved within 223 days.
Jason Cassorla’s has documented 103 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SGRY, Surgery Partners at 07-Aug-2024.
Analyst best performing recommendations are on CANO (CANO HEALTH).
The best stock recommendation documented was for CANO (CANO HEALTH) at 8/10/2022. The price target of $7 was fulfilled within 14 days with a profit of $2.26 (47.68%) receiving and performance score of 34.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 5 days ago
(26-Mar-2024)
1/5 (20%)
$4.31 (27.47%)
48
Hold
$10
$-0.05 (-0.50%)
$10
1 years 24 days ago
(07-Mar-2024)
3/3 (100%)
$0.1 (1.01%)
46
Sell
$11
$0.95 (9.45%)
$19
1 years 6 months 26 days ago
(05-Sep-2023)
1/2 (50%)
$2.29 (26.29%)
49
Hold
$13
$2.95 (29.35%)
$20
1 years 7 months 16 days ago
(15-Aug-2023)
0/5 (0%)
$1.86 (16.70%)
Buy
$13
$6.51 (100.31%)
$28
1 years 7 months 17 days ago
(15-Aug-2023)
1/3 (33.33%)
$4.47 (25.29%)
17
What Year was the first public recommendation made by Jason Cassorla?
